Abstract-Eosinophilic inflammation and airway remodeling are features of asthma. Eosinophil cationic protein (ECP) is released by activated eosinophils and transforming growth factor (TGF)-b 1 has major functions in the fibrotic process. We therefore hypothesized that ECP stimulates TGFb 1 release by human lung fibroblasts. Fibroblasts in monolayer displayed a constitutive release of TGF-b 1 , which increased in presence of ECP (436 T 60 vs. 365 T 48 pg/ml at 48 h; P < 0.01). mRNA expression of TGF-b 1 was almost twofold in ECP-stimulated fibroblasts. ECP in threedimensional cultures stimulated both TGF-b 1 release (180 T 61 vs. 137 T 54 pg/ml; P < 0.01) and fibroblast-mediated collagen gel contraction (28 vs. 39% of initial gel area at 48 h; P < 0.001). ECP stimulates TGF-b 1 -release by human lung fibroblasts, suggesting a potential mechanism for eosinophils in the fibrotic response. This may be an important mechanism by which ECP promotes remodeling of extra cellular matrix leading to airway fibrosis in asthmatics.
INTRODUCTION
Asthma is characterized by a chronic eosinophil inflammation combined with a subepithelial fibrosis in the airways [1] . The fibrosis is considered as an irreversible part of the airway obstruction and may be a hallmark of a more chronic and severe disease.
Eosinophils are recruited to the airway tissue during the asthmatic inflammatory process. Upon activation, they degranulate and release a variety of basic proteins such as eosinophil cationic protein (ECP), eosinophil peroxidase (EPO), eosinophil protein X (EPX) and major basic protein (MBP) [2, 3] . These mediators have a variety of biological activities including cytotoxic and immune regulatory effects. In this regard ECP seems to be of particular interest since it is one of the most potent proteins. Thus, ECP has been demonstrated to be involved not only in the specific defense against parasites but also in the inflammatory reaction in general [4] . High concentrations of ECP are measured in a variety of body fluids (serum, sputum, bronchoalveolar lavage) in asthmatics and in other inflammatory and fibrotic disorders [2] , indicating a role for the eosinophil and its mediators in the remodeling process.
Fibroblasts are the major type of mesenchymal cells present in the connective tissue matrix. Besides being structural cells, activated fibroblasts are capable of synthesizing and secreting a wide range of inflammatory mediators and matrix proteins including transforming growth factor (TGF)-b 1 and collagen [5] . Secretion of these mediators and matrix components is important in the amplification of the inflammatory response and has the potential to drive fibrotic tissue remodeling. For instance, TGF-b 1 enhances fibroblast and smooth muscle cell chemotaxis, myofibroblast differentiation and production of matrix proteins [6] .
In a recent study, we demonstrated that isolated human peripheral blood eosinophils stimulate fibroblast-mediated collagen gel contraction [7] , which is used to model the contractile process considered to be one aspect of fibrotic tissue remodeling [8Y13] . In addition, we identified ECP as a potential mediator in this process. Given the fact that eosinophils and ECP co-exist with fibroblasts in the airway tissue and thus can co-operate in tissue remodeling, we hypothesized that ECP acts through stimulating TGF-b 1 release by human lung fibroblasts. To test this hypothesis human lung fibroblasts were cultured both in monolayer and in three-dimensional collagen gels in presence of ECP. We measured the released protein and mRNA expression of TGF-b 1 . In addition, TGF-b 1 and ECP release in coculture of fibroblasts and whole eosinophils were determined.
MATERIALS AND METHODS

Materials
Native ECP was purified in high yields from buffy coats of leukocytes from healthy blood donors by a modified method described by [14] . Briefly, granules were prepared by nitrogen cavitation of the buffy coat leukocytes and separated from other organelles by ultra centrifugation. The granules were extracted by acid NaAc and the extract subjected to gel filtration on a Sephadex G-75 followed by ionexchange chromatography on Mono-S (Amersham Biotech, Uppsala, Sweden) and RPC (reversed phase chromatography). The purity was checked by SDS PAGE electrophoresis, Western blot analysis and Nterminal amino acid sequencing.
Type I collagen was extracted by 6 mM acetic acid from rat-tail tendons according to a previously published method [15] .
Lung Fibroblasts
Human fetal lung fibroblasts (HFL1) were obtained from the American Type Culture Collection (Rockville, MD, USA) and cultured as previously described [16] . Confluent HFL1 were trypsinized (0.05% trypsin, 0.2 g EDTAI4Na/l; SIGMA-ALDRICH, St Louis, Missouri, USA) before further culture studies.
Peripheral Blood Eosinophils
Buffy coats were obtained from non-allergic healthy blood donors. Eosinophils were isolated and purity of the eosinophil population was assessed by immunostaining as previously described [7] .
Determination of TGF-b 1 TGF-b 1 was analyzed both in monolayer and threedimensional (3D) collagen gel culture. In monolayer, HFL1 were seeded in Dulbecco_s Modified Eagle Medium (DMEM; SIGMA-ALDRICH), 10% fetal bovine serum (FBS; Invitrogen, Rockville, MD, USA) in 96-well tissue culture plates (FALCON; Franklin Lakes, NJ, USA) until 80% confluence. Cells were then starved for 24 h before stimulation with 1Y10 mg/ml native ECP (0.5% FBS) for 2Y48 h. Medium were collected at each time point. The 3D-culture floating collagen gels containing HFL1 alone or in combination with ECP (1Y10 mg/ml gel) or eosinophils (10 6 /ml gel) were cultured for 2 days before the medium surrounding the gels were collected. The collagen gels were dissolved in 0.5 ml collagenase type I (0.25 mg/ml; GIBCOBRL/Lifetechnologies, Rockville, MD, USA) by incubation at 37-C for 2Y3 h. Samples were centrifuged (400Âg, 10 min) and the supernatants were collected. All samples were stored at j20-C prior to TGF-b 1 analysis.
TGF-b 1 is synthesized as an inactive precursor, therefore samples must be activated before ELISA analysis. After activation, a measure of the total amount of released TGF-b 1 is achieved [17, 18] . TGF-b 1 released into the medium was determined by a commercially available quantitative sandwich enzyme immunoassay, ELISA (Quantikine\, Human TGF-b 1 Immunoassay, R&D systems, Minneapolis, MN, USA). The optical density (OD) was determined by a spectrophotometer (Anthos 2001, Labdesign, Täby, Sweden) by measuring absorbance (A) at 450 and 570 nm (reference wavelength). To exclude the possibility that ECP affect the TGF-b 1 ELISA, ECP was added to different TGF-b 1 concentrations included in the standard curve. This procedure did however not change the readout (data not shown).
Collagen Gel Contraction Assay
Collagen gels were prepared as previously described [19] . Briefly, HFL1 (3 Â 10 5 cells/ml gel) were cast together with ECP in various concentrations (1Y10 mg/ml gel) or eosinophils (10 6 /ml gel) in a 24-well tissue culture plate. After gelation (30 min at 37-C, 5% CO 2 ) the gels were transferred into 60-mm tissue culture dishes (FALCON) containing 5 ml of serum-free DMEM. The ability of ECP or eosinophils to affect fibroblast-mediated collagen gel contraction was determined by the slow contraction assay [8] . The floating gels were incubated at 37-C and 5% CO 2 for up to 4 days and the gel areas were measured daily by an image analyzer system (LEICA Microsystems AG; Wetzlar, Germany).
Determination of ECP
The concentrations of released ECP into medium surrounding co-culture (HFL1/eosinophils) in collagen gels were measured. Prior to analysis cetyldimethylethyl ammonium bromide was added to a final concentration of 0.2% and samples were kept in room temperature for 1 h. ECP was then measured by ECP-CAP-FEIA (Pharmacia, Uppsala, Sweden).
Cell Proliferation
Cell proliferation in monolayer culture was assayed according to manufacturer by the cell proliferation reagent WST-1 (Roche Diagnostics Scandinavia AB, Bromma, Sweden), which is a colorimetric assay based on the cleavage of the tetrazolium salt WST-1 by mitochondrial dehydrogenase in viable cells. HFL1 were cultured in 96-well tissue culture plates until 80% confluence, then starved 24 h before culturing with or without 10 mg ECP/ ml in DMEM, 0.5% FBS for 2 days. Samples were incubated with WST-1 for 2 h before absorbance (450/690 nm) was measured by a spectrophotometer (Anthos 2001).
In order to estimate cell numbers in gels cultured for 4 days, the DNA content was assayed fluorometrically with Hoechst dye 33258 (SIGMA-ALDRICH) by a previously published method [16] . Fluorescence intensities were measured with a fluorescence spectrometer (FL600 Fluorescence Microplate Reader, BIO-TEK, Winooski, Vermont, USA) with an excitation wavelength at 360 nm and an emission wavelength at 460 nm.
Extraction of Total RNA and cDNA Synthesis HFL1 were seeded in DMEM in 12-and 24-well tissue culture plates until 80% confluence and then starved 24 h prior to stimulation with ECP (10 mg/ml, 0.5% FBS) for 2Y24 h. Total RNA was extracted from HFL1 using the RNeasy extraction mini kit (Qiagen Inc., Valencia, CA, USA). The RNA was eluted in a final volume of 30 ml. RNA was then reversed transcribed from 10 ml of total RNA in a 20 ml final volume using 20 mM random hexamer primers, 200 mM of each deoxyribonucleoside triphosphate (dNTP), 40 U RNasin (all Pharmacia Biotech, Uppsala, Sweden) and 200 U Superscripti II RNase H-Reverse Transcriptase (Invitrogen), according to protocol and buffers supplied by the manufacturer.
Quantification of TGF-b 1 cDNA by Real Time-PCR
The basal and stimulated TGF-b 1 mRNA expression in HFL1 was quantified using the ABI Prism 7700 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) utilizing the 5 ¶ nuclease method (Taqman) with polymerase chain reaction (PCR) protocol: 95-C for 10 min, followed by 40 cycles of 95-C for 15 s and 60-C for 1 min. The PCR reaction was set up in a volume of 20 ml with 2 ml cDNA, 7 ml ddH 2 O, 1 ml primers and probe mix (Assays-on-Demandi Gene Expression Assay, Applied Biosystems), 10 ml master mix (Taqman\ Universal PCR Master Mix, Applied Biosystems). The housekeeping gene used was b-actin and all sequences of the primers and probes were commercially available. All samples were run in duplicates.
Statistical Analysis
Collagen gel contraction data are presented as mean of three replicate gels for each condition and standard error of mean (T SEM). As the batch of type I collagen and the number of cell passages can affect the assay, the data shown were taken from one representative experiment. The experiments were, however, repeated on multiple occasions. Groups of data were evaluated by analysis of variance (ANOVA), followed by TukeyYKramer or Bonferroni_s multiple comparisons test. Differences between two groups of data were analyzed by student_s t test. Significances were adjusted by Fischer_s exact test [20, 21] . All calculations were performed using the statistical package SAS system for Windows (SAS Institute Inc., Cary, NC, USA).
RESULTS
ECP Stimulates TGF-b 1 Release by Lung Fibroblasts
A significant increase in TGF-b 1 release was detected in supernatants from fibroblasts cultured with ECP in monolayer compared to unstimulated cells (Fig. 1) . TGF-b 1 release increased in a dose-dependent manner when 1Y10 mg ECP/ml was added to fibroblasts. In order to role out the time course of the ECP-induced TGF-b 1 release fibroblasts were stimulated 2Y48 h with 10 mg ECP/ml. Fibroblasts released TGF-b 1 constitutively and ECP-induced stimulation resulted in an increased TGF-b 1 release, which was most pronounced 48 h after stimulation (Fig. 2) . (Fig. 3) .
ECP Stimulates TGF-b 1 Release and Collagen Gel Contraction by Fibroblasts in Three-dimensional Culture
In order to stimulate fibroblasts in three-dimensional cultures, collagen gels were prepared and 1Y10 mg ECP/ml were added to fibroblast-populated collagen Fig. 1 . ECP stimulates TGF-b 1 release by human lung fibroblasts in a concentration dependent manner. HFL1 were cultured (0.5% FBS) and stimulated with 1Y10 mg ECP/ml (horizontal axis) for 48 h. Media were collected and TGF-b 1 concentrations were measured by ELISA. Vertical axis: TGF-b 1 concentration (pg/ml) after 2 days of ECP stimulation. Data are presented as mean and SEM, n = 7. *P < 0.05, **P < 0.01. gels. After a culture period of 2 days an increase in TGF-b 1 release was observed in ECP-stimulated samples. These increased TGF-b concentrations were observed both in collagen gels and in the surrounding medium (P <0.001 and 0.01, respectively) when 10 mg ECP/ml collagen gels were added (Fig. 4) .
A time dependent augmentation of gel contraction was observed during four constitutive days when ECP (10 mg/ml gel) was added to fibroblast-containing collagen gels (Fig. 5) . Thus, gels containing fibroblasts and ECP contracted more at each single point than the control (HFL1) gels from day one to four (P <0.001). The gels contracted most during the first 2 days. ECP added to gels without fibroblasts did not result in any gel contraction (data not shown).
Cell Proliferation
To assess whether ECP may stimulate fibroproliferation, an alternative explanation to increased TGF-b 1 release, cell proliferation was measured. The mitochondrial activity was assayed in monolayer culture, as a measurement of cell proliferation. No significant differences were observed when fibroblasts were stimulated with up to 10 mg ECP/ml. After 2 days of culture the OD-value (A 450 nm YA 690 nm ) for fibroblasts was 1.58 T 0.03 (mean T SEM) and for ECP-stimulated fibroblasts 1.52 T 0.04 (n=6; P> 0.05).
To further explore the possibility that ECP stimulate fibroproliferation, the level of DNA was measured in collagen gel cultures. No significant differences were detected after 2 days of culture. The OD-value (A 360 nm / A 460 nm ) was for fibroblasts 1,251 T 122 (mean T SEM, number, n = 5) and for ECP-stimulated (10 mg/ml) fibroblasts 1,242 T 122 (n= 6); P > 0.05.
Increased Release of ECP and TGF-b 1 in Collagen Co-culture of Lung Fibroblasts and Peripheral Blood Eosinophils
To improve the relevance of the observed ECPeffects on lung fibroblasts, medium from collagen gel Fig. 3 . mRNA expression of TGF-b 1 in human lung fibroblasts increases after 2 h of ECP-induced stimulation. Fibroblasts were cultured with or without 10 mg ECP/ml (0.5% FBS). Cells were captured after 2 h and RNA was isolated and transcribed to cDNA. TGF-b 1 was quantified by real time PCR. Controls (HFL1) were set to 1 and vertical axis shows mRNA expression of TGF-b 1 . Fig. 4 . ECP stimulates TGF-b 1 release by human lung fibroblasts in 3D-culture. ECP (10 mg/ml gel) were added to fibroblast-containing collagen gels. After 2 days of culture, media surrounding the gels were collected and collagen gels were dissolved in collagenase. TGF-b 1 concentrations were measured in media and gel supernatants by ELISA. Vertical axis: TGF-b 1 concentration (pg/ml) after 2 days of culture. Data are presented as mean and SEM, n = 5Y6. **P < 0.01, *** P< 0.001. co-culture of HFL1 and peripheral blood eosinophils were analyzed for both TGF-b 1 and ECP. Unstimulated fibroblasts in collagen gels released TGF-b 1 , which was significantly increased (143 T 65 vs. 330 T 58 pg/ml; P < 0.01) when fibroblasts were co-cultured with eosinophils (Fig. 6) . Eosinophils alone did not release any TGF-b 1 in our 3D-culture system. However, they were able to release ECP into the surrounding medium in which the gels were floated. This ECP release was significantly increased (59 T 17 vs. 93 T 16 ng/ml; P < 0.05) when the two cell types were cultured together. Thus, a 2-day co-culture of fibroblasts and eosinophils in collagen gels showed a significantly increase in both TGF-b 1 and ECP release compared to when either cell type was cultured alone.
DISCUSSION
In this study we demonstrate that ECP can stimulate human lung fibroblasts to increase its secretion of TGF-b 1 and to stimulate fibroblast-mediated 1 and ECP are released in co-culture. Fibroblasts (HFL1) and eosinophils (Eos) together or the cells separately were cast into collagen gels. After 2 days of culture, the surrounding media were analysed for TGF-b 1 by ELISA and ECP by ECP-CAP FEIA. *P < 0.05 co-culture vs. Eos, **P < 0.01 co-culture vs. HFL1. collagen gel contraction. Further, three-dimensional coculture of lung fibroblasts and peripheral blood eosinophils released increased levels of TGF-b 1 and ECP, suggesting a potential role for eosinophils in the fibrotic process that features asthma.
ECP is a basic granule protein released by activated eosinophils. Elevated levels of ECP have been detected in a variety of inflammatory and fibrotic disorders [2, 22] . For instance, ECP can be detected in sputum from asthmatics, and is used as a biomarker for eosinophilic inflammation. In vitro, it has been shown that ECP inhibits proteoglycan degradation in fibroblasts [23] , which gives a potential role for ECP in inflammation and remodeling. In the current study we postulate an additional role for ECP in the fibrotic response, i.e. stimulation of fibroblast TGF-b 1 secretion.
TGF-b exists in three isoforms [24] and TGF-b 1 is most linked to tissue fibrosis [25] . The ECP-induced stimulation of TGF-b 1 secretion by fibroblasts was dose-dependent, with 10 mg/ml giving the most pronounced effect. This concentration may be reached in vivo in extracellular matrix close to the fibroblasts when activated eosinophils degranulate. Our kinetic studies show that the most pronounced effect of ECP on TGFb 1 secretion by fibroblasts was observed after 2 days.
We also analyzed the mRNA expression of TGF-b 1 in ECP-stimulated fibroblasts and we demonstrated an almost twofold increase in mRNA expression for the cytokine. This indicates that ECP induces an active synthesis of the mediator and that the increased levels of TGF-b 1 are not merely a result from increased release of a pre-synthesized form.
To investigate if the increased TGF-b 1 release was a consequence of ECP-induced fibroproliferation, two different cell proliferation assays were used. The mitochondrial activity was measured in monolayer cultures and did not differ between stimulated and unstimulated cells. The DNA contents were determined in 3D-cultures. Neither here any significant differences were found. These data suggests that there is an increase in TGF-b 1 release on a single cell basis.
In order to strengthen the clinical relevance of our findings, we cultured fibroblasts in a three-dimensional collagen matrix, in addition to monolayer culture. This model is considered to be one aspect of tissue remodeling [7Y13, 16] . The advantage of culturing cells in a gel matrix is that cells allow spreading in a three-dimensional way like fibroblasts in vivo. Functional differences between fibroblasts cultured in monolayer and in 3D-gels have also been observed [26, 27] . We have previously shown, using the 3D-model, that co-cultured eosinophils can augment fibroblast-mediated collagen gel contraction in a time and dose dependent manner and that ECP may be one potential eosinophil-derived mediator [7] . In the present study we have extended these results showing that the ECP stimulation of fibroblast-mediated collagen gel contraction is timedependent. We also demonstrate that fibroblast gels stimulated with ECP release more TGF-b 1 than control gels. Since TGF-b 1 is a known stimulus of this assay [28] we propose that a potential mechanism responsible for at least partially of the ECP-induced stimulation is mediated through an increased release of fibroblast TGF-b 1 .
Finally, we have shown that co-culture of fibroblasts and eosinophils in collagen gels results in an increase of secretion of both ECP and TGF-b 1 compared to cultures of the two cell types alone. A correlation between these factors has also been observed in tissue [29, 30] . This further strengthens a specific role for eosinophils and ECP in the extracellular matrix of airway tissue during inflammation leading to fibrosis and that an extensive interplay between these two cell types exists which may promote the tissue remodeling process.
We conclude that ECP stimulates TGF-b 1 release by human lung fibroblasts, suggesting a potential mechanism for eosinophils in the fibrotic response. This may be an important mechanism by which ECP promotes remodeling of extra cellular matrix leading to subepithelial fibrosis in the airways of asthmatics.
